Synthesis of novel pyrazole–thiadiazole hybrid as potential potent and selective cyclooxygenase-2 (COX-2) inhibitors

Bioorg Med Chem Lett. 2014 Nov 15;24(22):5324-9. doi: 10.1016/j.bmcl.2014.08.062.

Abstract

A series of 1,3,4-trisubstituted pyrazole derivatives (3 a-f), (4 a-f), and (5 a-f) have been synthesized and evaluated for their cyclooxygenase (COX-1 and COX-2) inhibitory activity. The structures of newly synthesized compounds were characterized by IR, 1H NMR, and mass spectral analysis. All of the compounds showed good inhibition of COX-2 with IC50 of 1.33-17.5 μM. Among these derivatives, compound (5c) was the most potent and selective COX-2 inhibitor (IC50 = 1.33 μM), with a significant selectivity index (SI > 60). Molecular docking studies were carried out in order to predict the hypothetical binding mode of these compounds to the COX-2 isoenzyme. The result of present study suggests that pyrazole-thiadiazole hybrid could be an interesting approach for the design of new selective COX-2 inhibitory agents.

MeSH terms

  • Binding Sites
  • Cell Line
  • Cell Survival / drug effects
  • Cyclooxygenase 2 / chemistry*
  • Cyclooxygenase 2 / metabolism
  • Cyclooxygenase 2 Inhibitors / chemical synthesis*
  • Cyclooxygenase 2 Inhibitors / metabolism
  • Cyclooxygenase 2 Inhibitors / toxicity
  • Humans
  • Inhibitory Concentration 50
  • Molecular Docking Simulation
  • Protein Binding
  • Protein Structure, Tertiary
  • Pyrazoles / chemistry*
  • Structure-Activity Relationship
  • Thiadiazoles / chemistry*

Substances

  • Cyclooxygenase 2 Inhibitors
  • Pyrazoles
  • Thiadiazoles
  • pyrazole
  • Cyclooxygenase 2